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Nuclear reprogramming of differentiated cells can be induced by oocyte factors. Despite 
numerous attempts, these factors and mechanisms responsible for successful reprogramming remain 
elusive. Here, we identify one such factor, necessary for the development of nuclear transfer embryos, 
using porcine oocyte extracts in which some reprogramming events are recapitulated. After incubating 30 
somatic nuclei in oocyte extracts from the metaphase II stage, the oocyte proteins that were specifically 
and abundantly incorporated into the nuclei were identified by mass spectrometry. Among 25 identified 
proteins, we especially focused on a multifunctional protein, DJ-1. DJ-1 is present at a high 
concentration in oocytes from the germinal vesicle stage until embryos at the 4-cell stage. Inhibition of 
DJ-1 function compromises the development of nuclear transfer embryos but not that of fertilized 35 
embryos. Microarray analysis of nuclear transfer embryos in which DJ-1 function is inhibited shows 
perturbed expression of P53 pathway components. In addition, embryonic arrest of nuclear transfer 
embryos injected with anti-DJ-1 antibody is rescued by P53 inhibition. We conclude that DJ-1 is an 
oocyte factor that is required for development of nuclear transfer embryos. This study presents a means 
for identifying natural reprogramming factors in mammalian oocytes and a unique insight into the 40 












Embryonic cells differentiate into specific types of cells as development progresses. Once differentiated, 
the reversion of a differentiated cell state to an original undifferentiated state is strictly inhibited in 
normal development. However, it has been experimentally shown that differentiated nuclei can be 
returned to an undifferentiated embryonic state after nuclear transfer (NT) to enucleated eggs or oocytes 
(1, 2). Such experiments provide an opportunity to reprogram somatic cells as a means to prepare 55 
undifferentiated cells, which may be differentiated into any kinds of cells for cell-replacement therapy. 
Recently, nuclear reprogramming technology has been expanded by the production of induced 
pluripotent stem (iPS) cells (3). iPS cells can be obtained by overexpressing specific sets of transcription 
factors such as Oct4, Sox2, Klf4, and c-myc in cultured cells. The processes leading to establishment of 
iPS cell lines are being carefully examined and we are begining to understand how somatic cells acquire 60 
pluripotency by this method (4-6). The mechanisms leading to pluripotency may be different between 
iPS cells and NT embryos because somatic nuclei transferred into unfertilized metaphase II (MII) 
oocytes must undergo early embryonic development before the inner cell mass (ICM) can give rise to 
pluripotent embryonic stem (ES) cells. In addition, the molecules and mechanisms that induce somatic 
cell reprogramming are expected to be different between iPS cells and NT embryos (7, 8). A recent study 65 
has shown that nuclear transfer-mediated reprogramming resets differentiated cell states more efficiently 
than the iPS method (9). However, almost nothing is known about factors and mechanisms involved in 
the reprogramming of somatic cells by NT to mammalian oocytes. 
 Some proteins have been identified as reprogramming factors in Xenopus eggs and oocytes. 
These include ISWI (10), FRGY2a/b (11), BRG1 (12), Nucleoplasmin (13), and Histone B4 (14). While 70 
the roles of these factors on nuclear remodeling and transcriptional reprogramming have been shown, it 
has not been demonstrated that these factors are crucial for nuclear reprogramming in NT embryos 
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during embryonic development. 
 As shown above, reprogramming factors have been mainly identified in Xenopus. This is 
because Xenopus eggs and oocytes are extremely large and easily accessible, as compared to mammalian 75 
oocytes. These properties allowed development of cell-free systems using Xenopus egg or oocyte 
extracts. In the extracts, at least some reprogramming events are induced on large numbers of cells (105 
cells in 100 μl of extracts) (10, 15), allowing the study of reprogramming by biochemical means. In 
contrast to Xenopus, a system to study the molecular mechanisms underlying reprogramming has been 
lacking in mammalian oocytes. Recently, our group has developed a cell-free system from porcine 80 
oocytes (16). We have shown that a porcine oocyte extract from the metaphase II (MII) oocytes is able to 
displace transcription factors from donor nuclei and deacetylate the histone tails of somatic nuclei. These 
reprogramming events related to the erasure of gene-expression memories are also observed in somatic 
nuclei transferred to MII oocytes, suggesting that a part of reprogramming events can be reproduced in 
the oocyte extracts. Besides the character of the MII extracts, somatic nuclei can be fully reprogrammed 85 
to totipotency when transplanted in MII oocytes. Reprogramming factors related to totipotency are also 
present in oocytes at the germinal vesicle stage (GV) (17), and GV oocyte extracts induce 
reprogramming events, which are different from reprogramming in MII extracts, such as activation of 
pluripotent genes (16). However, the ability of these GV factors to reprogram transferred nuclei toward 
totipotency has never been directly shown because cloned offspring have never been obtained by direct 90 
injection of nuclei to GV oocytes. Taken together, MII oocyte extracts are ideal to explore 
reprogramming factors important for development of NT embryos as these factors might be accumulated 
and active. 
 In this study, we use porcine oocyte extracts to identify a unique oocyte factor involved in 
nuclear reprogramming toward totipotency. We focused on protein exchange in extract-treated nuclei 95 
because the exchange of nuclear proteins between a donor nucleus and an oocyte cytoplasm is a 
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prominent phenomenon during reprogramming (18-20). Additionally, some proteins, such as ISWI and 
nucleoplasmin, that are incorporated from Xenopus egg extracts into donor nuclei have been shown to 
have a role in reprogramming (10, 13). After incubation of somatic nuclei in oocyte extracts, proteins 
that become associated with somatic nuclei from the extracts were identified by mass spectrometry. The 100 
function of the identified proteins was then examined in NT embryos and cultured cells. These 




Identification of Oocyte Proteins That Associate with Somatic Nuclei. The strategy to identify a 
reprogramming factor in oocytes is diagramed in Fig. 1A. Briefly, porcine fibroblast cell nuclei were 
incubated in extracts from oocytes at the MII stage or the GV stage or extracts from fibroblast cells (own 
cell extracts). After the extract treatment, nuclei were collected and proteins were separated by 
two-dimensional polyacrylamide gel electrophoresis (2D PAGE) (Fig. 1B and Fig. S1). As shown in Fig. 110 
S1, nuclear proteins were greatly changed after oocyte-extract treatment, in agreement with a previous in 
vivo study in which nuclei were transferred into eggs (18). In particular, we focused on the proteins that 
were specifically and abundantly accumulated in nuclei after treatment with MII oocyte extracts. More 
than 60 unique protein spots were detected in MII-extract treated nuclei and these spots were excised 
and subjected to mass spectrometry. MALDI-TOF/TOF analysis and database searches revealed identity 115 
of 31 unique protein spots, and 25 proteins were finally identified (Fig. S2 and Table S1). Proteins were 
classified according to their function (Fig. S3A). Proteins with chaperone function were most commonly 
found, reflecting a marked change of nuclear proteins during reprogramming. Proteins related to DNA 
replication initiation were also found. This proteomic result agrees with a previous report (21) showing 
that reprogramming of somatic type replication forks to embryonic ones starts from the metaphase stage 120 
  
6
in oocyte extracts. Some examples of unique protein spots are shown in Fig. S3B. 
 
DJ-1 Is Incorporated in Oocyte Extracts Treated Nuclei. Two unique protein spots (20-25 kDa and pI 
5-7) were detected in the MII-extract treated nuclei (Fig. 1B, red box; and 1C, arrows). 
MALDI-TOF/TOF analysis and database searches revealed that these two spots were both matched to 125 
PARK7, also known as DJ-1. This result was repeated in three independent experiments using different 
oocyte extracts. Two spots of different pI were identified as DJ-1, because oxidized DJ-1 has a lower pI 
(22). Incorporation of DJ-1 protein into fibroblast cell nuclei after treatment with MII oocyte extracts 
was also observed by western blot (Fig. 1D) and immunofluorescence analysis (Fig. 1E). DJ-1 was also 
detected in nuclei treated with GV oocyte extracts (Fig. 1D), but the total amounts of incorporated DJ-1 130 
proteins were higher in those with MII oocyte extracts than GV oocyte extracts, agreeing with the 2D 
PAGE result (Fig. 1C). Considering that GV and MII oocyte extracts had similarly large amounts of 
DJ-1 (Fig. 1F) and both extracts have differential reprogramming abilities (16), greater incorporation of 
DJ-1 into cells treated with MII extracts may result from an active incorporation mechanism, implying 
that DJ-1 might have a specific role in MII oocytes extracts. 135 
 
Expression Pattern of DJ-1. In addition to the unique incorporation pattern of oocyte DJ-1 proteins to 
somatic nuclei, DJ-1 has been reported to interact with a known reprogramming factor, c-myc (23, 24). 
Large amounts of DJ-1 are stored in oocytes (Fig. 1F), while its function in early embryonic 
development has never been examined. For these interesting characteristics of DJ-1, we asked whether 140 
DJ-1 plays a role in nuclear transfer embryos. We first investigated its expression pattern. DJ-1 was 
abundantly expressed in all porcine organs examined (Fig. 2A). DJ-1 expression was examined in 
porcine oocytes and NT embryos. These transcripts and proteins were highly expressed throughout 
oocyte maturation and persisted until the 4-cell stage in NT embryos (Fig. 2B). Expression was 
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downregulated until the blastocyst stage (Fig. 2B). Generally, large amounts of DJ-1 proteins were 145 
detected throughout oocyte cytoplasm excluding lipid droplets (Fig. 2C). In oocytes at the GV stage, 
DJ-1 was present within the germinal vesicles as well as in cytoplasm (Fig. 2Ci, a germinal vesicle in the 
enlarged yellow box). It was dispersed in the MII oocyte cytoplasm (Fig. 2Cii) and on condensed MII 
chromosomes (Fig. 2D). Incorporation of DJ-1 into transferred donor nuclei was observed from 1 h after 
nuclear transfer although the signal is weaker than that in cytoplasm (Fig. 2 Ciii and E). Three h after 150 
nuclear transfer, nuclear DJ-1 is comparable to cytoplasmic DJ-1 (Fig. 2Civ) and it remained in nuclei 12 
h after transfer (Fig. 2Cv and F), suggesting that DJ-1 has been already incorporated into nuclei before 
entering the first S phase (25). Together, maternally accumulated DJ-1 was incorporated into transferred 
somatic nuclei in NT embryos. 
 155 
Inhibition of DJ-1 Function in NT Embryos. To test the role of DJ-1 on nuclear reprogramming, its 
function was inhibited in porcine NT embryos by several methods. Because DJ-1 is present in 
transferred nuclei 1 hour after NT, its function should be inhibited before introduction of donor nuclei 
into oocyte. However, neither siRNA injection nor antisense oligonucleotide injection during oocyte 
maturation caused significant degradation of maternal DJ-1 proteins although maternal mRNA was 160 
decreased (Fig. S4 A and B), indicating that it is difficult to reduce DJ-1 proteins during oocyte 
maturation. 
We then tried anti-DJ-1 antibody injection into MII oocytes before nuclear transfer, 
parthenogenetic activation (PA), and intracytoplasmic sperm injection (ICSI). The polyclonal antibody 
used here is raised against a peptide mapping near the N terminus of DJ-1 of human origin whose 165 
sequence matches perfectly to that of pig and is highly specific for recognizing the porcine DJ-1 among 
whole oocyte proteins (Fig. S4C). The antibody was injected into cytoplasm of MII oocytes more than 1 
h before fusion with donor cells in order to allow binding to maternal DJ-1. The proportion of embryos 
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that cleaved normally was less for NT embryos injected with anti-DJ-1 antibody (αDJ1-NT embryos) 
than control NT embryos injected with IgG (IgG-NT embryos), at 24, 27, and 30 hour after NT (Fig. S5), 170 
but the final proportion of normally cleaved embryos, judged 48 h after NT, was not different (Table 1). 
This result suggests that the first cleavage in αDJ1-NT embryos is delayed. Interestingly, the proportion 
of αDJ1-NT embryos that developed to the blastocyst stage was significantly lower than that of control 
IgG-NT and non-injected NT embryos (P < 0.004: 1.67 ± 1.67%, 13.40 ± 2.39% and 14.22 ± 2.92%, 
respectively) (Table 1). Similarly, significantly fewer embryos developed to the morula stage in 175 
αDJ1-NT embryos compared to controls (P < 0.002) (Table 1). Many of αDJ1-NT embryos arrested at 
the 2-cell or 4-cell stage. In contrast to NT embryos, anti-DJ-1 antibody injection to ICSI and PA 
embryos did not affect development to the morula and blastocyst stages (Table 1).  
Finally, DJ-1 was inhibited by injecting mRNA of DJ-1 dominant negative form [DJ1(L166P)] 
(26). Similar to the result of antibody injection, lower proportion of NT embryos injected with 180 
DJ1(L166P) mRNA developed to the morula and blastocyst stages, as compared with EGFP 
mRNA-injected or non-injected NT embryos, although proportion of cleaved embryos did not differ 
(Table 1).  
 
P53 Activation Is Involved in Developmental Arrest after Inhibition of DJ-1 Function. In order to 185 
uncover the basis for developmental arrest in DJ-1-antibody-injected NT embryos, global changes in 
gene expression were examined by Affymetrix porcine microarrays. NT embryos were collected 28 h 
after nuclear transfer when many of the embryos had just reached the 2-cell stage. We chose this stage 
because major zygotic genome activation occurs at the 4-cell stage, which might mask altered expression 
of direct target genes, and because DJ-1 seems to be active before the 2- or 4-cell stage. 190 
Global transcripts were compared among αDJ1-NT, IgG-NT, non-injected NT embryos, and 
donor cells. Comparing αDJ1-NT embryos and donor cells, 6411 probes (26.78%) were underexpressed 
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and 4256 probes (17.78%) were overexpressed among total 23,937 probes (≥2.0-fold), indicating a 
significant reprogramming in a large number of genes. To find genes affected specifically by DJ-1 
inhibition, we examined differentially-expressed probes comparing αDJ1-NT and IgG-NT embryos and 195 
401 downregulated probes (1.68%) and 349 upregulated probes (1.46%) were found. These genes were 
involved in RNA metabolism, oxidative stress, signaling pathways, and cell metabolism. DJ-1 has been 
reported to be engaged in these cellular processes (27-31). In particular, previous reports have identified 
a set of DJ-1 related genes using cultured cells, and the expression of these genes is largely disturbed in 
αDJ1-NT embryos (Ras oncogenes [RABL3: 2.3-fold down, RAP2C: 2.1-fold down, RAB26: 12.5-fold 200 
up] and serine/cysteine protease inhibitor [SERPINB1: 3.3-fold up]) (27, 32), suggesting that antibody 
injection specifically inhibited DJ-1 function in NT embryos. 
 Microarray analysis also showed that the expression of genes involved in P53 pathway were 
largely disturbed in αDJ1-NT embryos compared to IgG-NT as summarized in Fig. S6 (genes whose 
expression was upregulated or downregulated were marked with asterisk). Moreover, it is reported that 205 
DJ-1 inhibition is correlated with P53 activation (33, 34). We therefore decided to examine P53 
expression after DJ-1 inhibition. The correlation between P53 and DJ-1 expression was first examined 
in cultured cells. DJ-1 expression in porcine fibroblasts was efficiently and significantly inhibited at both 
transcriptional and translational levels by siRNA against pig DJ-1 (Fig. 3 A and B). Lipid droplets 
reminiscent of cellular stress appeared in the knockdown cells, but not control cells (Fig. S7, arrows). 210 
Upregulation of MDM2, a main regulator of P53, was observed in DJ-1 knockdown cells (Fig. 3A). 
Concomitantly, P53 and phospholylated P53 at the Serine 20 [P53(pS20)], which is a stabilized form of 
P53 (35), were slightly upregulated in DJ-1 knockdown cells (Fig. 3B). These results suggest that DJ-1 
inhibition induces activation of P53 in cultured cells.  
We examined whether P53 is similarly activated in DJ-1 deficient NT embryos. RT-PCR 215 
analysis showed MDM2 transcripts were only detected in porcine αDJ1-NT embryos (Fig. 3C), agreeing 
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with the result from DJ-1 knockdown in cultured cells. Faint bands of P53 and P53(pS20) proteins were 
detected in αDJ1-NT embryos although their expression did not show a clear difference between 
αDJ1-NT and control IgG-NT embryos (Fig. 3D, lanes 1 and 2). We further tested the correlation 
between P53 activation and the early embryonic arrest, P53 protein expression was compared between 220 
normal and arrested PA embryos at the 2-cell stage. Mitomycin C treatment (10 μM) with the 2-cell 
embryos caused developmental arrest of embryos and upregulated P53 proteins (Fig. 3D, lanes 3 and 4). 
Furthermore, when P53 expression was compared between the 2-cell embryos (day 2) and the arrested 
2-cell embryos (day 5), large amounts of P53 and P53(pS20) were accumulated in the arrested embryos 
(Fig. 3D, lanes 3 and 5). These results suggest that P53 activation is correlated with early embryonic 225 
arrest. Finally, we asked if P53 inhibition on αDJ1-NT embryos can rescue the early embryonic arrest. 
P53 was inhibited by a specific inhibitor, Pifithrin-α, at a concentration of 1 μM (36, 37). Remarkably, 
Pifithrin-α treatment successfully rescued the embryonic arrest of αDJ1-NT (Table 1). Pifithrin-α did not 
improve development of normal nuclear transfer embryos to the blastocyst stage (38), suggesting that a 
rescued phenotype observed by this inhibitor treatment should be specific to αDJ1-NT. These results 230 
indicate that embryonic arrest of αDJ1-NT can, at least to some extent, be attributed to P53 activation. 
Considering that DJ-1 inhibition did not change amounts of P53 transcripts (Fig. 3 A and C) and weakly 
changed total P53 protein amounts (Fig. 3 B and D), regulation of P53 activation by DJ-1 may be carried 
out at the post-translational level. This idea agrees with previous reports in which DJ-1 represses P53 





Factors necessary for the successful reprogramming of somatic cells by mammalian oocytes have been 240 
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explored since the first successful production of the cloned sheep (2). Although more than a decade has 
passed, they remain largely unknown, partly because many biochemical analyses have not been applied 
to oocytes and embryos whose quantities are limited. Here, we used functional oocyte extracts to 
overcome this issue and combined them with proteome analysis. We have identified an oocyte factor, 
DJ-1, necessary for the successful development of porcine NT embryos. 245 
 DJ-1 was initially identified as an oncogene that transformed mouse NIH3T3 cells weakly on 
its own and more strongly in combination with Ras (24). Further studies have revealed that DJ-1 has 
multiple functions (Fig. S6). DJ-1 modulates the PTEN/Akt survival pathway (30, 41), suppresses 
Ask1-mediated apoptosis (42), has RNA binding activity (28) and chaperone activity (43), and protects 
cells from oxidative stress (44). DJ-1 is a dimeric protein and has some structural similarities with heat 250 
shock proteins (45). Deletion and a point mutation (L166P) of DJ-1 that disrupts normal dimer 
formation are responsible for the onset of familiar Parkinson’s disease (46). In germ cells, high amounts 
of expression in testis and sperm have been reported and disturbed testicular DJ-1 expression is related 
to male infertility (47). We find that large amounts of DJ-1 are accumulated in oocytes during oogenesis 
(Fig. 2 B and C). Nevertheless, nothing is known about the role of maternally stored DJ-1 on early 255 
embryonic development.  
 Inhibition of maternal DJ-1 function indicated that DJ-1 is indispensable for early embryonic 
development in NT embryos (Table 1). Furthermore, microarray analysis revealed that the P53 pathway 
is disturbed in DJ1-NT embryos compared to control IgG-NT embryos (Fig. S6). P53 responds to 
diverse cellular stresses and induces cell cycle arrest, apoptosis, cell senescence, or DNA repair. P53 260 
expression is mainly regulated by MDM2, which binds to and targets p53 for ubiquitin-dependent 
proteolysis (48, 49). It has been generally considered that P53 and MDM2 exist as an autoregulatory 
feedback loop; MDM2 transcription is induced by P53 and in turn inactivates P53 by ubiquitination. 
Therefore, activation of MDM2 is often due to elevated P53 activity as was observed in this study (Fig. 
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3A). P53 activation critically affects embryonic viability (50, 51). Its activation also plays a crucial role 265 
in reprogramming somatic cells toward iPS cells (52-56). However, it has not been revealed whether P53 
activation is involved in reprogramming of NT embryos. Our study shows that P53 activation is 
implicated in embryonic arrest in NT embryos. Interestingly, other identified oocyte proteins that are 
associated with somatic nuclei (Table S1), such as HSP27 (57), 14-3-3-zeta (58), and HSP90 (59), are 
reported to repress P53 activity. Several oocyte factors may synergistically inhibit P53 activation in NT 270 
embryos. 
One of the interesting properties that DJ-1 possesses is that its function is necessary only for 
NT embryos, but not for ICSI and PA embryos (Table 1). NT embryos undergo higher rates of apoptosis 
(60) and are less tolerant to in vitro culture environment than fertilized embryos (61). Lower levels of 
gene expression related to cell protection from stress and apoptosis have been reported in NT embryos, 275 
compared to fertilized embryos (62). Considering that NT embryos are experimentally produced whereas 
fertilized embryos are made by the natural process, it is reasonable to think that transferred somatic 
nuclei undergo higher cellular stress than sperms. This notion is supported by the fact that NT embryos 
exhibit higher rates of apoptosis and weaker stress-coping functions than fertilized embryos (60-62). 
Nevertheless, proportion of NT embryos that develop to the blastocyst stage is similar to that of in vitro 280 
fertilized embryos in many reports. This comparable developmental ability to the blastocyst stage 
implies that oocytes intrinsically possess robust mechanisms to relieve cellular stresses and these 
mechanisms might work as a safeguard to ensure preimplantation development of NT embryos. These 
stress-coping mechanisms are probably relying on many different molecules since we found a lot of 
anti-stress proteins by mass spectorometry (Table S1). DJ-1 is one of the key players among these 285 
proteins and the lack of DJ-1 function has a detrimental effect on NT embryos, suggesting that the other 
redundant factors with stress-coping functions may not be sufficient to complement DJ-1 function in NT 
embryos. In contrast, the loss of DJ-1 in fertilized embryos might not be as harmful as in NT embryos 
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because fertilized embryos have less cellular stress and/or stronger stress-coping functions than NT 
embryos as described above. 290 
 Thus far, many studies have focused on chromatin remodeling proteins and transcription 
factors as reprogramming-related factors in oocytes. DJ-1 rather acts as a positive regulator of cell 
survival by modulating signaling pathways than by directly modifying chromatin structures. Our results 
show that such a process is critical for nuclear reprogramming in embryos. This notion is further 
supported by a recent publication in which inhibition of HDAC6 that is involved in induction of 295 
apoptosis responding to cellular stress greatly improves cloning efficiency in mice (63). During 
reprogramming, original cell states are forced to change. This process must be accompanied by a lot of 
cellular stresses. DJ-1 may relieve those stresses and protect NT embryos. Exploring downstream 
networks of DJ-1 in embryos might provide further clues to the long-standing question why cloned 
embryos are able to develop to term. 300 
 
 
Materials and Methods 
Oocyte-Extract Treatment. Porcine oocyte extracts were prepared as described previously (16). Briefly, 
1000-1200 of GV oocytes or 800 of in vitro matured MII oocytes were collected. After denudation and 305 
zona pellucid removal, oocytes were suspended in 4-5 μl of extraction buffer (50 mM KCl, 5 mM MgCl2, 
5 mM EGTA, 2 mM 2-mercaptoethanol, 0.1 mM PMSF, protease inhibitor cocktail, and 50 mM HEPES, 
pH 7.6) containing an energy-regenerating system (2 mM ATP, 20 mM phosphocreatine, 20 U/ml 
creatine kinase, and 2 mM GTP). Oocytes were disrupted by ultra-centrifugation and the oocyte 
components were extracted. These extract solutions were kept on ice before use. Porcine fibroblast cells 310 
were treated with 30 μg/ml digitonin (Calbiochem) for permeabilization (64). Cell nuclei (2 × 105) were 
incubated in the oocyte extracts or fibroblast-cell extracts for 1 h at 37oC. After the incubation, nuclei 
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were suspended in sucrose buffer (75 mM KCl, 4 mM MgCl2, 250 mM sucrose, 0.5 mM spermidine 
trihydrochloride, 0.15 mM spermine tetrahydrochloride, 1 mM DTT, 10 mM β-glycerophosphate, 
protease-inhibitor cocktail, and 10 mM HEPES pH:7.8) and collected by centriguation. Nuclear pellets 315 
were dissolved in 150 μl of the lysis buffer (7M urea, 2M thiourea, 4% CHAPS, bromophenolblue, 
protease inhibitor, and phosphatase inhibitor) and these samples were used for 2D PAGE. For the 
purpose of protein identification, five different samples were pooled, which equals about 4,000 oocytes. 
 
Statistical Analysis. The differences of developmental abilities of embryos were analyzed by student’s 320 
t-test. A P value of less than 0.05 was considered statistically significant. SI Materials and Methods 
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Fig. 1. Identification of protein DJ-1 as a candidate reprogramming factor present in the MII oocytes. 
(A) Schematic diagram of the strategy to identify reprogramming factors in oocytes. (B) Total protein of 
nuclei treated with MII oocyte extracts (MII-EXT) separated by 2D PAGE. The gel marked by the red 
square box (20-25 kDa) contains protein DJ-1 spots. pI means isoelectric point. (C) DJ-1 spots (arrows) 485 
in different nuclear samples from MII-EXT, GV oocyte-extract-treated cells (GV-EXT), fibroblast 
extract-treated cells (Fibro-EXT), and permeabilized cells without extract treatment (Non treatment). (D) 
Western blotting on fibroblast nuclei after extract treatment. Incorporation of DJ-1 proteins into nuclei 
was detected using a DJ-1 specific antibody. Histone H2B was used as a loading control. (E) 
Immunofluorescence analysis of DJ-1 in nuclei after treatment with MII oocyte extracts. DNA was 490 
stained with propidium iodide. (Scale bar: 10 μm.). (F) Large amounts of DJ-1 are present in both GV 




Fig. 2. DJ-1 expression in porcine tissues, oocytes, and nuclear transfer embryos. (A) DJ-1 proteins 
exist in various types of tissues examined by western blotting. (B) Expression of DJ-1 transcripts and 495 
proteins was examined in oocytes (GV and MII stages) and NT embryos during preimplantation 
development. The graph shows the relative expression levels of DJ-1 transcripts examined by 
semiquantitative RT-PCR (normalized by ACTB transcripts). The number of oocytes and embryos used 
for western blotting are as follows; GV:8, MII:8, 2 cell: 8, 4 cell: 7, Morula: 2, Blast: 3. Error bars, mean 
± SEM. (C) Localization of DJ-1 protein in oocytes and NT embryos, observed by immunofluorescence 500 
analysis. Each panel shows a whole oocyte or NT embryo, with an enlargement of the yellow boxed area 
shown to the lower right. The enlarged areas contain nuclei of oocytes or NT embryos. White area shows 
staining with anti-DJ1 antibody. i: GV oocyte, ii: MII oocyte, iii: NT embryo 1 h after nuclear transfer, 
iv: NT embryo 3 h after transfer, v: NT embryo 12 h after transfer. A red arrow in ii represents a first 
polar body in a MII oocyte. (Scale bar: 100 μm.). (D) Distribution of DJ-1 in a MII nucleus at high 505 
magnification. Yellow color on merged photos (Merge) represents nuclear localization of DJ-1. (E) DJ-1 
distribution in transferred fibroblast nuclei 1 h after nuclear transfer into a MII oocyte. The border 
between nucleus and oocyte cytoplasm was marked with dotted white lines. (F) DJ-1 in transferred 




Fig. 3. Activation of P53 after inhibition of DJ-1. (A) RT-PCR analysis of cultured porcine fibroblast 
cells after knockdown of DJ-1 by specific siRNA. DJ-1 expression was specifically inhibited by siRNA 
and, at the same time, activation of MDM2 was observed. Duration (h) after siRNA transfection was 
indicated. (B) Activation of P53 after knockdown of DJ-1 in porcine fibroblasts was examined by 
western blotting analysis (left panel). The right graph represents the relative band intensities of P53, 515 
P53(pS20), and DJ-1 when standardized with TUBULIN. P53 and Phosphorylated P53 at serine 20 
[P53(pS20)] was significantly upregulated, while DJ-1 was successfully downregulated by knockdown. 
Error bars, mean ± SEM (t-test, n = 3). (C) Transcripts in NT embryos injected with anti-DJ-1 antibody 
(αDJ1) or IgG (IgG) were examined by RT-PCR analysis. MDM2 was only detected in embryos injected 
with DJ-1 antibody. (D) Activation of P53 was examined in NT and PA embryos by western blotting 520 
analysis. Anti-DJ-1 antibody was injected into NT embryos (αDJ1, lane 1) and IgG was injected as a 
control (IgG, lane 2). NT embryos were collected 72 h after nuclear transfer. For western blots of PA 
embryos, three types of 2-cell stage PA embryos were collected; non-treated embryos were collected 48 
h after parthenogenetic activation (2cell, lane 3), Mitomycin C was added to the culture medium from 24 
h to 48 h after activation and sampling was performed at 48 h (2cell MC, lane 4), and embryos arrested 525 
at the 2 cell stage were collected at 120 h (2cell arrested, lane 5). 
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embryos 1st cleavage (%) Morulae (%) Blastocysts (%) 
Embryos arrested at 
the 2- and 4-cell 
stages (%) 
NT embryos 
a. anti-DJ1-injected embryos 6 103 70 (68.04±5.04%) 3 (2.50±2.50%)b,d,e,f,g 2 (1.67±1.67%)d,f,g 59 (57.61±4.27%)b,d,f
b. anti-DJ1-injected (+Pifithrin-α) 3 35 26 (75.37±6.94%) 8 (21.10±5.09%)a 6 (12.98±9.40%) 11 (34.78±7.97%)a 
c. anti-DJ1-injected (+DMSO) 3 33 26 (75.56±8.89%) 3 (7.22±3.89%)d,f,g 2 (4.44±4.44%) 20 (61.11±5.56%)d,f
d. IgG-injected embryos 6 111 73 (64.76±4.52%) 26 (25.41±4.81%)a,c 15 (13.40±2.39%)a 36 (30.31±5.34%)a,c
e. DJ1(L166P) mRNA-injected embryos 4 74 53 (71.07±5.23%) 10 (13.04±1.96%)a,f,g 5 (6.25±2.39%) 35 (46.43±7.92%) 
f. EGFP mRNA-injected embryos 4 83 57 (68.30±5.48%) 19 (23.16±1.90%)a,c,e 11 (13.08±3.47%)a 30 (35.65±4.81%)a,c
g. Control (Non-injected embryos) 4 134 93 (68.94±2.43%) 28 (21.07±1.05%)a,c,e 19 (14.22±2.92%)a n.d. † 
ICSI embryos 
anti-DJ1-injected embryos 5 63 21 (33.06±0.85%) 18 (28.55±1.82%) 18 (28.55±1.82%) 3 (4.51±2.09%) 
IgG-injected embryos 5 60 21 (34.58±1.33%) 17 (27.86±1.56%) 17 (27.86±1.56%) 4 (6.72±1.88%) 
Control (Non-injected embryos) 5 68 25 (36.15±2.36%) 21 (30.82±0.65%) 21 (30.82±0.65%) 4 (5.33±2.26%) 
PA embryos 
anti-DJ1-injected embryos 3 63 49 (76.18±3.21%) n.d. 33 (51.99±5.03%) n.d. 
IgG-injected embryos 3 72 58 (79.39±2.56%) n.d. 39 (51.49±6.79%) n.d. 
*Three experimental groups are set as NT (nuclear transfer) embryos, ICSI (intracytoplasmic sperm injection) embryos, and PA (parthenogenetically activated) 
embryos. DJ-1-injected embryos represent the embryos injected with antibody against DJ-1. Similarly, IgG-, DJ1(L166P) mRNA-, and EGFP mRNA-injected 
embryos are shown. 
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a～gEach sample in NT embryos is expressed as a-g, and samples that show significant differences within the same column in NT embryos are indicated as 
superscripts (P<0.05). For example, sample f shows significant differences from a, c, and e in development to the morula stage. ICSI and PA embryos do not show 
any significant differences. Percentages are expressed as mean±SEM 
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SI Materials and Methods 
Proteomic Analysis. Total protein concentrations were determined by the modified Bradford-HCl assay 
using γ-globulin as a standard and aligned among all samples. Separation of proteins by 
first-dimensional IEF electrophoresis was performed using IPG gels (Immobiline DryStrip, pH 3–11 NL, 
GE Healthcare). The strips were transferred onto SDS-PAGE gels. After the 2D PAGE, gels were 30 
stained with Sypro Ruby (Invitrogen). Differentially expressed spots were picked up manually and 
subjected to in-gel trypsin digestion. MS spectrometric analysis of the tryptic digests was performed 
using a 4700 MALDI-TOF/TOF mass spectrometer (Applied Biosystems). To identify proteins, sets of 
MS and MS/MS spectra were subjected to MS/MS Ion search (Matrix Science) against Swiss Prot or 
NCBI mammalian protein database. 35 
 
Embryo Manipulation. Porcine nuclear transfer was performed as described previously (1). Porcine 
fibroblast cells from an adult male Meishan pig were cultured in DMEM with 10% FBS and used for 
donor cells within passage 8. Five pl of antibody solution or 10 pl of 500 ng/μl poly(A)-tailed RNA was 
injected into enucleated oocytes. After injection of antibody, embryos were kept for at least 1 h before 40 
fusion with donor cells, which allows the antibody to bind endogenous DJ-1. Total number of cleaved 
embryos was judged 48 h after nuclear transfer. Porcine ICSI followed the previous protocol (2) and the 
antibody was injected at least 1 h before sperm injection. Antibodies used are as follows: DJ-1 (sc-27004, 
Santa Cruz), rabbit IgG (sc-2027, Santa Cruz), and goat IgG (sc-2028, Santa Cruz). 
 45 
Gene Expression Analyses. Incorporation of DJ-1 protein into extract-treated nuclei and distribution of 
DJ-1 protein in oocytes and embryos were examined by immunofluorescence analysis. The following 
antibody was used: DJ-1 (sc-27004). Anti-goat secondary antibody conjugated with Alexa488 
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(Invitrogen) was used. Nuclei were stained with propidium iodide. The amounts of proteins expressed in 
cells, oocytes, and embryos were measured by western blotting. The following primary antibodies were 50 
used: DJ-1 (sc-27004), P53 (628201, Biolegend), P53(S20) (DR1023, CALBIOCHEM or 55427, 
ANASPEC), Histone H2B (07-371, Millipore), β-Actin (clone AC15, Sigma), and Tubulin (T9026, 
Sigma). Anti-Tubulin, anti-Histone H2B, and anti-β-Actin antibodies were used for standardization. The 
blots were visualized using Immobilon Western HRP Substrate (Millipore). The amounts of transcripts 
expressed were measured by RT-PCR analysis. Total RNA from cells or from oocytes and embryos was 55 
extracted by a phenol-chloroform method or by Picopure RNA extraction kit (Arcturus), respectively. 
Purified RNA was reverse transcribed by ReverTra Ace (TOYOBO) and PCR reaction was performed by 
ExTaq (Takara) or KOD plus. Primers used are listed on Table S2. In both analyses, the band intensities 
were determined by a model 4.0 ATTO densitograph (ATTO). 
 60 
Microarray Analysis. Nuclear transfer embryos (23-26 embryos per each sample) were collected 28 h 
after nuclear transfer. Total RNA was purified by the use of Picopure RNA extraction kit. Two rounds of 
amplification for isolated RNA were performed for microarray analysis (3). The final yield of 
biotinylated cRNA was hybridized to the Affymetrix GeneChip Porcine Genome Array. The output data 
were analyzed with GeneSpring software (Agilent). 65 
 
Plasmid Construction, RNA Synthesis, and Transfection. Site-directed mutagenesis was induced by 
different primer sets containing a point mutation (Table S2) to generate constructed plasmids containing 
pig DJ1(L166P) cDNA. The plasmids were used as templates for in vitro transcription. RNA synthesis 
and poly(A) tailing were performed with MEGAscript T7 kit (Ambion). Antisense oligonucleotid and 70 
siRNA against porcine DJ-1 were designed and the sequences are listed on Table S2. DJ-1 siRNA was 
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Fig. S1.  Fibroblast cell nuclei were treated with oocyte extracts and nuclear proteins were separated 
by 2D PAGE. MII-EXT: MII oocyte-extract-treated cells, GV-EXT: GV oocyte-extract-treated cells, 













Fig. S2.  Protein spots identified by MS/MS analysis. Protein spots marked by red circles were 
specifically and abundantly expressed in MII oocyte-extract-treated cells (MII-EXT). The number on the 
2D PAGE gel corresponds to the Spot No in Table S1. MII-EXT: MII oocyte-extract-treated cells. pI 












Fig. S3.  Oocyte proteins that are specifically and abundantly accumulated in somatic nuclei after 
treatment with MII oocyte extracts. (A) Identified proteins are classified according to their cellular 125 
function. (B) Some examples of proteins that are highly expressed in MII oocyte-extract-treated cells 
(MII-EXT). Protein spots are indicated by arrows. GV-EXT: GV oocyte-extract-treated cells, 





Fig. S4.  Inhibition of DJ-1 expression and specificity of anti-DJ-1 antibody. (A) siRNA against DJ-1 
was injected into GV oocytes and then in vitro matured to the MII stage. Although DJ-1 transcripts were 
somewhat decreased, no significant degradation of DJ-1 proteins was observed during oocyte maturation. 
As a control, EGFP mRNA was injected at the same time. β-Actin (ACTB) was used as a loading control. 
(B) Oocytes injected with antisense oligonucleotide against pig DJ-1 were in vitro matured to the MII 135 
oocytes and specific inhibition of DJ-1 expression was examined. Although transcripts were efficiently 
downregulated by the antisense oligonucleotide, no apparent degradation of DJ-1 proteins was detected 
(AS). As a control, sense oligonucleotide (S) and EGFP mRNA were injected. β-Actin was used as a 
loading control. (C) Goat polyclonal antibody against human DJ-1 specifically recognized porcine DJ-1 







Fig. S5.  Timing of first cleavage was compared between NT embryos injected with DJ-1 antibody 145 
(DJ1-NT) and those with IgG (IgG-NT). The y axis represents ratios of cleaved embryos at different 













Fig. S6.  Molecular networks related to P53 and DJ-1 are depicted. Signaling pathways and 
relationship among these genes are shown. These pathways are based on published reports. Genes whose 
expression was disrupted after inhibition of DJ-1 function in nuclear transfer embryos in this report are 160 
marked with asterisk. The abnormal expression was detected by microarray analysis (more than 2-fold 
differences), RT-PCR, western blotting analysis, or inhibitor treatment for P53. Large sets of genes and 
molecular pathways are perturbed after DJ-1 inhibition in NT embryos including some critical genes 









Fig. S7.  Fibroblast cells after treatment with specific siRNA against DJ-1. Many lipid droplets (some 
of them were marked with arrows) were accumulated 24 h after transfection with siRNA against pig 














Table S1. Oocyte Proteins That Are Incorporated into Somatic Nuclei during Incubation in MII Oocyte Extracts 
Spot 
No.* Protein Name  Accession ID Mascot PS a Classification 
1-3 Peroxiredoxin-2 - Sus scrofa (Pig) PRDX2_PIG 420,366,344 Anti oxidation 
4 Heat shock protein HSP 90-alpha - Bos taurus (Bovine) HSA90A_BOVIN 376 Chaperone 
5, 6 Proliferating cell nuclear antigen - Bos taurus (Bovine) PCNA_BOVIN 214,278 DNA replication 
7 Ubiquitin thioesterase OTUB1 - Homo sapiens (Human) OTUB1_HUMAN 102 Ubiquitin enzyme 
8, 9 Protein DJ-1 - Bos taurus (Bovine) PARK_BOVIN 33,144 Chaperon, Oncogene 
10 Heat shock protein beta-1 - Bos taurus (Bovine) HSPB1_BOVIN  72 Chaperone 
11 14-3-3 protein zeta/delta - Bos taurus (Bovine) 1433Z_BOVIN 94 Oncogene 
12, 13 Ubiquitin carboxyl-terminal hydrolase isozyme L1 - Sus scrofa (Pig) UCHL1_PIG 224,76 Ubiquitin enzyme 
14 Heat shock cognate 71 kDa protein - Equus caballus (Horse) HSP7C_HORSE 117 Chaperone 
Protein-arginine deiminase type-6 - Homo sapiens (Human) PADI6_HUMAN 63 Arginine deiminase 
15 Medium-chain specific acyl-CoA dehydrogenase, mitochondrial precursor 
- Sus scrofa (Pig) ACADM_PIG 107 Mitochondria 
16 Peroxiredoxin-4 - Bos taurus (Bovine) PRDX4_BOVIN 47 Anti oxidation 
17 Thioredoxin-dependent peroxide reductase, mitochondrial precursor - Bos 
taurus (Bovine) PRDX3_BOVIN 121 Mitochondria 
18 Polymerase delta-interacting protein 2 - Homo sapiens (Human) PDIP2_HUMAN 87 DNA replication 
19 Alcohol dehydrogenase [NADP+] - Sus scrofa (Pig) AK1A1_PIG 112 Metabolism 
20 DNA replication complex GINS protein PSF1 - Bos taurus (Bovine) PSF1_BOVIN 67 DNA replication 
21 Uncharacterized protein C6orf118 - Homo sapiens (Human) 75 Others 
22 Alpha-enolase - Homo sapiens (Human) ENOA_HUMAN 74 Glycolytic enzyme 
23 Actin, aortic smooth muscle - Bos taurus (Bovine) ACTA_BOVIN 37 Cytoskeleton 
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24 Lamin-A/C - Sus scrofa (Pig) LMNA_PIG 230 Nuclear membrane 
25 PREDICTED: similar to Nitrilase family, member 2 [Pan troglodytes] gi|114588194  105 Putativel tumor suppressor 
26 Vimentin - Homo sapiens (Human) VIME_HUMAN 229 Cytoskeleton 
27 DnaJ homolog subfamily B member 11 precursor - Canis familiaris (Dog) DJB11_CANFA 213 Chaperone 
28-30 Galactokinase - Bos taurus (Bovine) GALK1_BOVIN 102,130,177 Metabolism 
31 Spermine synthase - Bos taurus (Bovine) SPSY_BOVIN 300 Metabolism 
*See Figure S2. 



















Table S2. Primer, siRNA, and oligonucleotide sequences 
Gene Forward Primer (5’-3’) Reverse Primer (5’-3’) 
A. Gene expression analysis (pig genes) 
ACTB GCCCATCTACGAGGGGTACG CACGTCGCACTTCATGATCG 
DJ-1 CGAGGTTCAGTTAAGTCTTCAGA CGGGAGGGTTCCGGGCAGCCCGCTCG  
MDM2 AATGAATCCTCCCCTTCCAC TTGGGATAGGAAGGCTTGTG 
P53 CCTCACCATCATCACACTGG GGCTTCTTCTTTTGCACTGG 
















C. siRNA against pig DJ-1 
sense GAAGCAAAGUUACGACGCAUU 
antisense UUCUUCGUUUCAAUGCUGCGU 
D. Oligonucleotide against pig DJ-1 
DJ-1 sense CAGAAAATACAACATAAGAATGGCT 
DJ-1 
antisense 
AGCCATTCTTATGTTGTATTTTCTG 
 
 
 
